Used in the pharmaceutical industry as an active ingredient in medications for managing type 2 diabetes. It functions as a sodium-glucose co-transporter 2 (SGLT2) inhibitor, helping to lower blood glucose levels by promoting the excretion of excess glucose through urine. This mechanism operates independently of insulin action, making it suitable for patients with insulin resistance.

This compound supports glycemic control and is often prescribed as part of a comprehensive treatment plan that includes diet and exercise. It may also contribute to reductions in body weight and blood pressure due to the excretion of glucose and fluids, offering additional benefits for diabetic patients who are overweight or have hypertension.

Furthermore, research indicates that SGLT2 inhibitors may reduce the risk of heart failure and chronic kidney disease in patients with long-term diabetes, providing long-term benefits in preventing complications from the disease.